A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities (Q41644696)

6 October 2017

title

A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities (English)

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

10 November 2022

author name string

B. Rose

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

A. Gillespie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

D. Wunderlich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

J. A. Barbosa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

K. Cahill

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

J. Dzuiba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

D. Shedd

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

B. Zerler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1731187

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1731187

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:016158909290164S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

https://api.elsevier.com/content/article/PII:016158909290164S?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

10 November 2022

1 reference

6 October 2017

volume

29

1 reference

6 October 2017

issue

1

1 reference

6 October 2017

page(s)

131-144

1 reference

Human leukocyte IgG Fc receptors

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

The immune response against therapeutic monoclonal antibodies

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Current stage of interleukin 2 receptor targeted therapy

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

The nucleotide sequence of a human immnnoglobulin Cγlgene

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Characterization of the human receptor for T-cell growth factor

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity.

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Metabolic properties of IgG subclasses in man

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mA

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Evidence for additional subunits associated to the mouse interleukin 2 receptor p55/p75 complex

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Possible association between IL-2 receptors and class I HLA molecules on T cells

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Interleukin-2: inception, impact, and implications

10 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts

10 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter

10 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

An associated molecule, p64, with high-affinity interleukin 2 receptor

10 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

Complications and monitoring of OKT3 therapy

10 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes

10 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

The interleukin 2 receptor. Functional consequences of its bimolecular structure

10 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0161-5890(92)90164-S

10 November 2022

Identifiers

1 reference

release_q4gcgq4x7fdnhib36xtqaosmju

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q4gcgq4x7fdnhib36xtqaosmju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference